Publications

Export 34 results:
Sort by: Author Title Type [ Year  (Desc)]
2022
2021
Navarro-Compan, V., A. Boelb, A. Boonen, P. Mease, R. Landewe, U. Kiltz, M. Dougados, X. Baraliakos, W. Bautista-Molano, H. Carlier, et al., "The ASAS-OMERACT core domain set for axial spondyloarthritis", Seminars in Arthritis and Rheumatism, vol. 51, issue 6, pp. 1242 - 1249, 2021.
Navarro-Compán, V., A. Sepriano, B. El-Zorkany, and D. van der Heijde, "Axial spondyloarthritis", Annals of the Rheumatic Diseases, vol. 80, issue 12, pp. 1511-1521, 2021. Axial spondyloarthritis
Ziade1, N., T. Arayssi, B. E. Zorkany, A. Daher, G. A. Karam, M. A. J. M. A. Mashaleh, A. Aiko, E. Alam, S. A. Emadi, M. A. Mashaleh, et al., "Development of an Educational Video for Self-Assessment οf Patients with RA: Steps, Challenges, and Responses", MEDITERRANEAN JOURNAL OF RHEUMATOLOGY, vol. 32, issue 1, pp. 66 - 73, 2021.
Zorkany, B. E., A. Mokbel, S. M. Gamal, I. Hmamouchi, and M. Dougados, "Does smoking afect level of seropositivity in RA? A post‑HOC global and inter‑country analysis of COMORA cohort", Rheumatology International, vol. 41, issue 4, pp. 699 - 705, 2021.
López-Medina, C., S. Chevret, A. Molto, J. Sieper, T. Duruöz, U. Kiltz, B. E. Zorkany, N. Hajjaj-Hassouni, R. Burgos-Vargas, J. Maldonado-Cocco, et al., "Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA study", Rheumatic & Musculoskeletal Disease (RMD), vol. 7 , issue 3, pp. 1 - 12, 2021.
Ziadé, N., S. Saad, M. A. Mashaleh, L. El Kibbi, B. E. Zorkany, H. Badsha, G. Harif, A. Daher, N. Salloum, N. Salloum, et al., "Perceptions of patients with rheumatoid arthritis about self assessment of disease activity after watching an educational video: a qualitative pilot study", Rheumatology International, vol. 41, issue 4, pp. 733 - 740, 2021.
López-Medina, C., A. Molto, J. Sieper, T. Duruöz, U. Kiltz, B. E. Zorkany, N. Hajjaj-Hassouni, R. Burgos-Vargas, J. Maldonado-Cocco, N. Ziade, et al., "Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study.", RMD open, vol. 7, issue 1, 2021. Abstract

OBJECTIVES: To characterise peripheral musculoskeletal involvement in patients with spondyloarthritis (SpA) including psoriatic arthritis (PsA), across the world.

METHODS: Cross-sectional study with 24 participating countries. Patients with a diagnosis of axial SpA (axSpA), peripheral SpA (pSpA) or PsA according to their rheumatologist were included. The investigators were asked which diagnosis out of a list of six (axSpA, PsA, pSpA, inflammatory bowel disease-associated SpA, reactive arthritis or juvenile SpA (Juv-SpA)) fitted the patient best. Peripheral manifestations (ie, peripheral joint disease, enthesitis, dactylitis and root joint disease), their localisation and treatments were evaluated.

RESULTS: A total of 4465 patients were included (61% men, mean age 44.5 years) from four geographic areas: Latin America (n=538), Europe plus North America (n=1677), Asia (n=975) and the Middle East plus North Africa (n=1275). Of those, 78% had ever suffered from at least one peripheral musculoskeletal manifestation; 57% had peripheral joint disease, 44% had enthesitis and 15% had dactylitis. Latin American had far more often peripheral joint disease (80%) than patients from other areas. Patients with PsA had predominantly upper limb and small joint involvement (52%).Hip and shoulder involvement was found in 34% of patients. The prevalence of enthesitis ranged between 41% in patients with axSpA and 65% in patients with Juv-SpA. Dactylitis was most frequent among patients with PsA (37%).

CONCLUSION: These results suggest that all peripheral features can be found in all subtypes of SpA, and that differences are quantitative rather than qualitative. In a high proportion of patients, axial and peripheral manifestations coincided. These findings reconfirm SpA clinical subtypes are descendants of the same underlying disease, called SpA.

López-Medina, C., A. Molto, J. Sieper, T. Duruöz, U. Kiltz, B. E. Zorkany, N. Hajjaj-Hassouni, R. Burgos-Vargas, J. Maldonado-Cocco, N. Ziade, et al., "Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASASPerSpA study", Rheumatic & Musculoskeletal Disease (RMD), vol. 7 , issue 1, pp. 1 - 12, 2021.
2020
Abdulateef, N., D. Yasiry, Y. A. Hummadi, A. Adnan, B. Elzorkani, B. K. Masri, M. Khouy, S. Alkurash, H. M. A. Rayes, A. Alkadi, et al., "The Management of Rheumatic Disease in the Era of COVID-19. Recommendations by ArLAR (Arab League Associations for Rheumatology)", International Medical Journal (IMJ), vol. 25, issue 06, pp. 2587-2594, 2020. 2020_the-management-of-rheumatic-disease-in-the-era-of-covid-19-recommendations-by-arlar-arab-league-associations-for-rheumatology-5ef53b47c486d.pdf
Zorkany, B. E., Y. M. Ali, R. Namas, M. Bedaiwi, W. Husain, H. M. Ahmed, and N. Ziade Zoghbi, "The treatment journey for patients with axial spondyloarthritis in North Africa and the Middle East: From diagnosis to management.", International journal of rheumatic diseases, vol. 23, issue 11, pp. 1574-1580, 2020. Abstract2020_treatment_journay-printed_manuscript_11-2020.pdf

The management of axial spondyloarthritis (axSpA) is challenging worldwide, and the particular challenges shared by North Africa and the Middle East are mainly related to early diagnosis and standardized management. We believe there are several reasons for these challenges, including: (a) limited awareness of the disease manifestations and prevalence in the region among physicians; (b) the concept of nonradiographic axSpA, while accepted with some difficulty by the rheumatology community, may not be well understood by the referring primary care physicians; (c) access to, and training in magnetic resonance imaging varies greatly between countries in the North Africa and Middle East region, and this may have a large impact on early diagnosis; (d) country-specific treatment guidelines are unavailable; and (e) economic and cultural factors influence patients' attempts to seek and continue treatment. In this review, we will discuss the prevalence of axSpA in North Africa and the Middle East, as well as the challenges to diagnose and treat patients in this region. As rheumatologists practicing in North Africa and the Middle East, we also provide suggestions to assist physicians, other healthcare professionals, and researchers in facilitating early, accurate diagnosis and treatment of axSpA.

2019
Bird, P., W. Bensen, B. El-Zorkany, J. Kaine, B. H. Manapat-Reyes, V. k Pascual-Ramos, D. Witcombe, K. Soma, R. Zhang, and K. Thirunavukkarasu, "Tofacitinib 5 mg Twice Daily in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs A Comprehensive Review of Phase 3 Efficacy and Safety", JCR: Journal of Clinical Rheumatology, vol. 25-3, issue 03, pp. 115-126, 2019. original_article_tofacitinib_out_of_jcr.pdf
2018
Kiltz, U., D. van der Heijde, A. Boonen, N. Akkoc, J. C. - C. W. 6 Wilson Bautista-Molano, 5 Ruben Burgos-Vargas, R. Burgos-Vargas, J. C. - C. Wei, P. Chiowchanwisawakit, M. Dougados, T. M. Duruoz, et al., "Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis", Ann Rheum Dis, pp. 1-7, 2018. kiltz_measurement_properties_asas__hi_annrheumdis-2017-212076.full_.pdf
2017
Darzi, A., M. Harfouche, T. Arayssi, S. A. Emadi, K. A. Alnaqbi, H. Badsha, F. A. Balushi, B. E. Zorkany, H. Halabi, M. Hamoudeh, et al., "Adaptation of the 2015 American College of Rheumatology Treatment Guideline for Rheumatoid Arthritis for the Eastern Mediterranian Region: an examplar of the GRADE Adolopment", Health and Quality of Life Outcomes (2017), 2017. adaptation_of_the_2015_american_college.pdf
Molto, A., L. Gossec, B. Meghnathi, R. B. M. Landewé, D. van der Heijde, P. Atagunduz, B. K. Elzorkany, N. Akkoc, U. Kiltz, J. Gu, et al., "An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDAS", ARD (Ann Rheum Dis), 2017. an_assessment_...etc_annrheumdis-2017-212178.full_.pdf
CHEN, D. - Y., C. S. LAU, B. E. Zorkany, P. - N. HSU, S. PRAPROTNIK, R. VASILESCU, L. MARSHALL, and L. LLAMADO, Dosing down and then discontinuing biologic therapy in rheumatoid arthritis: a review of the literature, , 2017. dosing_down_and_then_discontinuing_biologic_therapy_in.pdf
Kiltz, U., D. van der Heijde, A. Boonen, W. Bautista-Molano, R. Burgos-Fargas, P. Chiowchanwisawaket, T. Duruos, B. El-Zorkany, I. Essers, I. Gaydukova, et al., "Measuring impairments of functioning and health in patients with axial spondylorarthritis by using the ASAS Health Index and the Environmental Item Set: translation and cross-cultural adaptation into 15 languages", Rheumatic & Musculskeletal Diseases (RMD), 2017. measuring_impairments_......pdf
2016
U, K., H. van der D, B. A, B. J, B. Molano, B. Vargas, P. Chiowchanwisawakit, M. Dougados, B. K. El-Zorkany, and Gaudukova, "Validation of the ASAS Health Index: results of a multicenter international study in 23 countries", Annual European Congress of Rheumatology EULAR 2016, London, UK, 8-11 June, 2016. eular_2016_validation_asas_hi_working_group_v5_1.doc
Al-Emadi, S., F. Abutiban, E. B. Zorkany, N. Ziade, A. Al-Herz, M. Al-Maini, B. Khan, A. Ghanem, A. H. Rayes, A. J. Saleh, et al., "Enhancing the care of women with rheumatic diseases during pregnancy: challenges and unmet needs in the Middle East", Clin Rheumatol, vol. 35, issue 1, pp. 25-31, 2016. enhancing_the_care_of_women_with_rheumatic_diseases.pdf
Molto, A., A. Etcheto, D. van der Heijde, R. Landewe, F. van den Bosch, W. B. Molano, R. Burgos-Vargas, P. P. Cheung, E. Collantes-Esteves, A. Deodhar, et al., "Prevalence of comorbidities and evaluation of their screening in spondyloarthitis: results of the international cross-sectional ASAS-COMOSPA study", Ann Rheum Dis, vol. 75, issue 6, pp. 1016-1023, 2016.
2015
2014
Bird, P., W. Bensen, B. El-Zorkany, J. Kaine, B. H. Manapat-Reyes, V. Pascual-Ramos, D. Witcombe, and A. Anisfeld, "Comprehensive Summary of the Efficacy and Safety of Tofacitinib 5mg Twice Daily in Patients with Rheumatoid Arthritis and an Inadequate Response to Disease-Modifying Antirheumatic Drugs", ACR CONFEX 2014, Boston Convention and Exhibition Center, 16 November, 2014. 2014-10-31-00-18-42.png
Tourism